Company Filing History:
Years Active: 2003-2019
Title: Innovations of Kenneth Rosenthal in Cancer and Autoimmune Disease Treatment
Introduction
Kenneth Rosenthal is a notable inventor based in Akron, OH (US), recognized for his contributions to the field of immunology. He holds 2 patents that focus on innovative methods for treating cancer and autoimmune diseases. His work has significant implications for advancing therapeutic strategies in these critical areas of health.
Latest Patents
One of Kenneth Rosenthal's latest patents is a method for inducing an immune response for the treatment of cancer and autoimmune diseases or conditions. This invention involves peptide constructs, which are polypeptides created by linking together two or more peptides derived from different molecules. These constructs are designed to treat or prevent cancer and manage autoimmune diseases. The peptide constructs have the formula P-x-P, where P is a peptide associated with forms of cancer or an autoimmune condition. This innovative approach can cause the maturation of immature dendritic cells, which can then be administered to modulate or initiate an immune response against cancer cells.
Another significant patent is for an immunogenic conjugated polypeptide for the treatment of herpes simplex virus. This invention includes peptide constructs that are chemically synthesized to contain a specific antigenic peptide from the Herpes Simplex Virus, which elicits a TH1-like response in vitro tests in mice. These constructs have shown protective effects against challenges with HSV, highlighting their potential in therapeutic applications.
Career Highlights
Kenneth Rosenthal is currently associated with Cel-Sci Corporation, where he continues to develop innovative solutions in immunotherapy. His work is pivotal in the ongoing research and development of treatments that harness the body's immune system to combat diseases.
Collaborations
Kenneth has collaborated with notable colleagues, including Daniel H. Zimmerman and Eyal Talor, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kenneth Rosenthal's contributions to the field of immunology through his patents reflect his commitment to advancing medical science. His innovative approaches to treating cancer and autoimmune diseases hold promise for improving patient outcomes and enhancing therapeutic options.